In the first several years after the discovery of this disorder, the success rate of healthy pregnancy outcomes was minimal. However, an increase in knowledge and medications available to women during pregnancy has given APS patients a great advantage to those in the past. Under that care and guidance of well-informed specialist, an APS patient has nearly the same chance of delivering a healthy baby as a woman without the disorder.

It is suggested that an APS patient be under the care of a physician capable of handling high risk patients. Most specialists with a working knowledge of APS will add an 81mg aspirin and injections of Lovenox® to the daily routine with the prenatal vitamin other take alone. Both the aspirin and Lovenox® are forms of "blood thinners." This is to help prevent clots from forming in the placenta. After the 32nd week of pregnancy, Lovenox® injections are replaced with heparin because of the risk of bleeding during childbirth. Heparin has a shorter half-life than Lovenox® and reduces the chance of a bleed simply because of the time factor.

After delivery, the baby (if born full term) should have no further complications related to his mother's blood clotting disorder. However, the mother will be resuming anticoagulants for at least six weeks after the birth due to clotting risk during the post partum period.